File:Schematic representation of delivery or induction of OSKM factors to convert somatic cells into pluripotent cells and differentiation the iPSC into a wide range of individual cells from the three germ layers.png
From Wikimedia Commons, the free media repository
Jump to navigation
Jump to search
Size of this preview: 800 × 530 pixels. Other resolutions: 320 × 212 pixels | 640 × 424 pixels | 1,024 × 678 pixels | 1,280 × 848 pixels | 2,560 × 1,696 pixels | 3,706 × 2,455 pixels.
Original file (3,706 × 2,455 pixels, file size: 1.41 MB, MIME type: image/png)
File information
Structured data
Captions
Summary[edit]
DescriptionSchematic representation of delivery or induction of OSKM factors to convert somatic cells into pluripotent cells and differentiation the iPSC into a wide range of individual cells from the three germ layers.png |
English: A comprehensive understanding of the pathophysiology and cellular responses to drugs in human heart disease is limited by species differences between humans and experimental animals. In addition, isolation of human cardiomyocytes (CMs) is complicated because cells obtained by biopsy do not proliferate to provide sufficient numbers of cells for preclinical studies in vitro. Interestingly, the discovery of human-induced pluripotent stem cell (hiPSC) has opened up the possibility of generating and studying heart disease in a culture dish. The combination of reprogramming and genome editing technologies to generate a broad spectrum of human heart diseases in vitro offers a great opportunity to elucidate gene function and mechanisms. However, to exploit the potential applications of hiPSC-derived-CMs for drug testing and studying adult-onset cardiac disease, a full functional characterization of maturation and metabolic traits is required. In this review, we focus on methods to reprogram somatic cells into hiPSC and the solutions for overcome immaturity of the hiPSC-derived-CMs to mimic the structure and physiological properties of the adult human CMs to accurately model disease and test drug safety. Finally, we discuss how to improve the culture, differentiation, and purification of CMs to obtain sufficient numbers of desired types of hiPSC-derived-CMs for disease modeling and drug development platform. |
Date | |
Source | https://www.mdpi.com/2073-4409/10/12/3483 |
Author | Bekhite, Mohamed M., and P. Christian Schulze. |
Licensing[edit]
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 08:23, 17 December 2023 | 3,706 × 2,455 (1.41 MB) | DoctorNaturopath (talk | contribs) | Uploaded a work by Bekhite, Mohamed M., and P. Christian Schulze. from https://www.mdpi.com/2073-4409/10/12/3483 with UploadWizard |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.
File usage on other wikis
The following other wikis use this file:
- Usage on uk.wikipedia.org
Hidden category: